Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023
SINGAPORE, Jan. 7, 2024 /PRNewswire/ — Juniper Biologics (“Juniper“), a global science-led pharmaceutical company headquartered in Singapore, proudly announces its latest achievement, winning the award for Molecular Science & Technology Acquisition of the Year at Acquisition International’s M&A Awards 2023. This recognition highlights Juniper’s unwavering commitment to advancing treatments in oncology-supportive care and its overarching mission … Read more